- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sun Pharma Advanced Research Company Ltd (SPRC)
Track today's live Sun Pharma Adv. Research (SPRC) share price, performance and key data on this page with our current NSE:SPRC stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Sun Pharma Adv. Research share price on the NSE exchange. Use the dropdown to switch exchange for the SPRC share price, head to our technical summary section, which provides analysis on Sun Pharma Adv. Research share price buy/sell indicators using real-time data (or discuss the Sun Pharma Adv. Research (SPRC) stock price today with other investors in the Sun Pharma Adv. Research NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:SPRC share price (ISIN: INE232I01014) to enhance your trading decisions with our free investment tools and resources.
What Is the Sun Pharma Advanced Research Company Ltd Share Price Today?
The Sun Pharma Adv. Research share price today is 198.58.
What Is the Stock Symbol for Sun Pharma Advanced Research Company Ltd
The stock symbol (or 'ticker') for Sun Pharma Advanced Research Company Ltd is "SPRC."
What Stock Exchange Does Sun Pharma Advanced Research Company Ltd Trade On?
Sun Pharma Advanced Research Company Ltd is listed and trades on the NSE stock exchange.
Is Sun Pharma Advanced Research Company Ltd a Good Stock to Buy?
Determining whether Sun Pharma Adv. Research (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:SPRC share price (ISIN: INE232I01014) to enhance your trading decisions with our free investment tools and resources.
What Is the Sun Pharma Advanced Research Company Ltd Share Price Today?
The Sun Pharma Adv. Research share price today is 198.58.
What Is the Stock Symbol for Sun Pharma Advanced Research Company Ltd
The stock symbol (or 'ticker') for Sun Pharma Advanced Research Company Ltd is "SPRC."
What Stock Exchange Does Sun Pharma Advanced Research Company Ltd Trade On?
Sun Pharma Advanced Research Company Ltd is listed and trades on the NSE stock exchange.
Is Sun Pharma Advanced Research Company Ltd a Good Stock to Buy?
Determining whether Sun Pharma Adv. Research (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
198.58
-9.13(-4.40%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
195.01
207.00
52 wk Range
108.00
289.00
SPRC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
195.01207.00
52 wk Range
108.00289.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SPRC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell
Earnings
Latest Release
10/08/2026
EPS / Forecast
-0.64 / --
Revenue / Forecast
399.2M / --
Compare SPRC to Peers and Sector
Metrics to compare | SPRC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSPRCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 4.2x | 39.2x | −0.4x | |
PEG Ratio | 0.01 | −0.51 | 0.00 | |
Price/Book | 4.9x | 1.6x | 2.6x | |
Price / LTM Sales | 3.4x | 1.5x | 3.1x | |
Upside (Analyst Target) | - | 8.9% | 47.7% | |
Fair Value Upside | Unlock | 6.1% | 6.5% | Unlock |
Sun Pharma Advanced Research Company Limited engages in the research and development of pharmaceutical products in India and internationally. It develops Sezaby, a benzyl alcohol and propylene glycol free formulation of phenobarbital sodium injection for the treatment of neonatal seizures; SPARC-121, a novel topical agent for the treatment of Alopecia Areata; and SPARC-122, an anti-MUC1 ADC for treatment of multiple cancer indications. The company is also involved in the development of PDP-716 for treatment of open-angle glaucoma. Sun Pharma Advanced Research Company Limited was incorporated in 2006 and is based in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sun Pharma Adv. Research (NSE: SPRC) Share Price Today?
The Sun Pharma Adv. Research stock price today is 198.58 INR.
What Stock Exchange Does Sun Pharma Adv. Research (SPRC) Trade On?
Sun Pharma Adv. Research is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Sun Pharma Adv. Research?
The stock symbol (also called a 'ticker') for Sun Pharma Adv. Research is "SPRC."
What Is the Current Sun Pharma Adv. Research Market Capitalisation?
As of today, Sun Pharma Adv. Research (NSE: SPRC) market cap is 64.45B INR.
What Is Sun Pharma Adv. Research's (SPRC) Earnings Per Share (TTM)?
The Sun Pharma Adv. Research EPS is currently 48.80 (Trailing Twelve Months).
Is SPRC a Buy or Sell From a Technical Analyst Perspective?
Based on today's Sun Pharma Adv. Research moving averages and other technical indicators, the daily buy/sell signal for SPRC stock is Strong Sell.
How Many Times Has Sun Pharma Adv. Research Stock Split?
Sun Pharma Adv. Research has split 2 times. (See the SPRC stock split history page for full effective split date and price information.)
How Many Employees Does Sun Pharma Adv. Research Have?
Sun Pharma Adv. Research has 279 employees, based on their latest Companies House report.
What is the current trading status of Sun Pharma Adv. Research (NSE: SPRC)?
As of 31/08/2026, Sun Pharma Adv. Research (SPRC) is trading at a share price of 198.58 INR, with a previous close of 207.71 INR. The stock has fluctuated within a day range of 195.01 INR to 207.00 INR, while its 52-week range spans from 108.00 INR to 289.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.